Schedule a meeting

Care Pathways

with real evidence

Non-Alcoholic Steatohepatitis

Post-Consultation Follow-up Obesity

Obesity

Hypertension

Pre-Therapy Antineoplastic Screening

Non-Alcoholic Steatohepatitis

Post-Consultation Follow-up Obesity

Obesity

Emergency Triage

Diabetes

Pediatrics

Pre-Consultation Anamnesis

Depression

Emergency Triage

Diabetes

Pediatrics

Generalized Anxiety Disorder Coronary Artery Disease (CAD)

Coronary Artery Disease Chronic Kidney Disease (CKD)

Chronic Kidney Disease

Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease Generalized Anxiety Disorder (GAD)

Generalized Anxiety Disorder Coronary Artery Disease (CAD)

Coronary Artery Disease Chronic Kidney Disease (CKD)

Chronic Kidney Disease

Chronic Obstructive Pulmonary Disease

Monitor your patients remotely and prioritize who needs it most.
Measurable results in the 1st month of implementation.

Choose a care pathway

AI agent trained to improve your clinical outcomes.

All Chronics Routine Pharma Statement of Health

Non-Alcoholic Steatohepatitis

Goal: Identify at-risk patients, classify disease severity to guide appropriate management, and implement lifestyle changes.

Ref.: American Association for the Study of Liver Diseases (AASLD) - EUA

Patient

Pre-Therapy Antineoplastic Screening

Goal: Identify early risks, adjust doses, minimize side effects, and standardize criteria for systemic therapy.

Ref.: STAR (Systemic Therapy Assessment Routine)

Patient

Claims Declaration

Goal: Ensure fast and accurate notification of events that trigger the policy, guaranteeing transparency and rigor in claims analysis.

Ref.: Association of Insurance Supervisors - CH

Proposer

Emergency Triage

Goal: Classify cases by severity to prioritize urgent care, use a structured method to avoid assessment errors, direct patients correctly to optimize flow and care.

Ref.: Manchester Triage Group (MTG) - UK

Patient

Generalized Anxiety Disorder (GAD)

Goal: Assess and inform the patient about the disorder and involve them in treatment, monitor side effects, use assessment scales to measure anxiety levels during follow-up.

Ref.: American Psychiatric Association (APA) - EUA

Patient

Pre-Consultation Anamnesis

Goal: Standardize the anamnesis and ensure control of information during follow-up.

Ref.: World Health Organization (WHO)

Patient

Chronic Obstructive Pulmonary Disease (COPD)

Goal: Identify COPD in its early stages, reduce the severity of exacerbations with prevention strategies, encourage physical exercises, and cessation of smoking.

Ref.: Global Initiative for Chronic Obstructive Lung Disease (GOLD) - EUA

Patient

Pediatrics

Goal: Guarantee healthy growth of the child and prevent diseases, detect deficiencies early, reinforce good care practices and follow up the vaccination to reduce infant mortality.

Ref.: World Health Organization (WHO)

Patient

Depression

Goal: Improve quality of life, prevent relapses with monitoring strategies, promote treatment adherence, ensuring regular follow-up and family support.

Ref.: World Health Organization (WHO) - CH

Patient

Post-Consultation Follow-up

Goal: Monitor the progression of symptoms and the effectiveness of treatment, identify potential adverse reactions, reinforce recommendations to ensure understanding and adherence.

Ref.: World Health Organization (WHO)

Patient

PHS Binary

Goal: Implement a standardized decision-making process, ensuring clear and consistent assessments with transparency in the criteria used.

Ref.: Association of Insurance Supervisors - CH

Proposer

Chronic Kidney Disease (CKD)

Goal: Detect CKD in its early stages, monitor and treat complications, reduce cardiovascular risk, implement strategies to slow kidney function decline.